Brandtree

Hypera: brands it owns and its ownership tree

Hypera (B3: HYPE3) is a publicly listed company headquartered in São Paulo, Brazil that owns 8 consumer brands across 3 categories.[1]

Hypera Pharma is a Brazilian pharmaceutical company that began operating in December 2001 as a consumer goods business and moved into medicines in 2007, selling its cosmetics and disposables operations in 2015 and 2017. It leads the Brazilian over-the-counter medicines market and has been listed on B3's Novo Mercado since 2008. Votorantim S.A. joined its controlling shareholder group in 2025.

Company facts

Legal name
Hypera Pharma (also Hypera)
Type
publicly listed company · see all publicly listed company owners
Headquarters
🇧🇷 São Paulo, Brazil
Founded
2001
Tickers
B3: HYPE3
Website
www.hypera.com.br
Last verified
· 1 sources

Hypera in numbers

Everything Hypera owns

Controlling ownership as of . Brands grouped under the entity that owns them; large groups are collapsed.

Everything Hypera owns Tree of 8 brands under Hypera. Hypera Benegrip Biotônico Fontoura Doril Engov Epocler Estomazil Mantecorp Skincare Zero-Cal

Full-screen interactive tree → · Download as infographic

Brand portfolio by category

Full portfolio, 8 brands, with sources → · Competitors by shared categories →

Latest news about Hypera

No tagged news items yet. Deals, regulatory actions and recalls are added from SEC filings, regulators and trade press; only titles and links are stored.

Headlines link to the original publisher. Brandtree does not reproduce article text.

Frequently asked questions

What brands does Hypera own?

Hypera owns 8 consumer brands tracked here, including Benegrip, Mantecorp Skincare, Engov, Zero-Cal, Doril and Biotônico Fontoura.

Is Hypera a Brazilian company?

Yes. Hypera is headquartered in São Paulo, Brazil and was founded in 2001.

Who owns Hypera?

Hypera is a publicly listed company owned by its shareholders; it trades as HYPE3 on the B3.

Sources (1) & corrections

Last verified . Every ownership fact above is backed by one of these primary documents. Numbers in brackets in the text refer to this list.

  1. [1] Hypera Pharma — Corporate Profile (investor relations, updated 18 June 2026) — Hypera Pharma, Official document, published 18 June 2026; retrieved 16 September 2026.

Report a correction Opens a pre-filled GitHub issue. See our corrections policy.